
Acurx Pharmaceuticals, Inc. (ACXP)
Last updated: 2026-10-23 18:31:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Acurx Pharmaceuticals, Inc. (ACXP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.13, with a market capitalization of $4.94M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.05 to $7.54. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$4.94M | |
$1.14 | |
$176.40 | |
$1.05 | |
$1.14 | |
19.03K | |
122.23K | |
-- | |
$7.54 | |
$1.05 | |
-- | |
-- |
Acurx Pharmaceuticals, Inc. (ACXP) Stock Price Today
Acurx Pharmaceuticals, Inc. (ACXP) is currently trading at $1.13 as of 2026-10-23 18:26:00, down 0.88% ($0.01) from the previous close of $1.14
During today's regular trading session, ACXP has traded between $1.05 and $176.40, with a trading volume of 19.03K shares. The current price is near the lower end of today's range.
Acurx Pharmaceuticals, Inc. (ACXP) 7-Day Stock Price Change
Over the past seven days, Acurx Pharmaceuticals, Inc. (ACXP) moved from $1.15 to $1.13, representing a decline of 1.74% ($0.02).
The stock traded between $1.05 and $1.22 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 74.40 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
ACXP 52-Week Price Position
Position in Range: 1.2%
ACXP is currently trading at $1.13, placing it 1.2% of the way from its 52-week low of $1.05 to its 52-week high of $7.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Acurx Pharmaceuticals, Inc. (ACXP)?
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.
Acurx Pharmaceuticals, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 4 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Acurx Pharmaceuticals, Inc. (ACXP) Stock on MEXC
Eligible investors can buy real shares of Acurx Pharmaceuticals, Inc. (ACXP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Acurx Pharmaceuticals, Inc. (ACXP) stock price today?
2.Is ACXP stock going up or down today?
3.What is ACXP pre-market price?
4.What is ACXP after-hours price?
5.Is ACXP stock trading now?
6.Where does ACXP sit relative to its 52-week high and low?
7.What sector is Acurx Pharmaceuticals, Inc. in?
8.What is Acurx Pharmaceuticals, Inc.'s market capitalization and where is it listed?
9.How is ACXP valued in terms of P/E ratio and EPS?
10.Does Acurx Pharmaceuticals, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ACXP Stock Calculator
Estimate the value between ACXP shares and USD.
ACXP Shares to USD
1.00 ACXP shares = 1.13 USD
Calculations are estimates based on the latest available price and are for reference only.


